Answers are grounded in this paper and cite their sources.
Background Epilepsy is an important comorbidity in autism, but clinic-specific evidence from Uganda is limited. This study aimed to estimate the prevalence of recorded epilepsy and examine associated clinical characteristics among children with autism spectrum disorder (ASD) attending a specialist neurology clinic in Kampala, Uganda. Methods This retrospective cross-sectional study examined an extract of 221 electronic clinical records for children aged 2–17 years attending St Francis Hospital Nsambya during December 2020–December 2025. Seventeen unavailable or nonbinary epilepsy outcomes were treated as missing. Analysis of 204 records used Wilson 95% confidence intervals (CIs) and modified Poisson regression with robust standard errors, adjusting for sex, both age variables, and developmental category. Results Recorded epilepsy was present in 59/204 children (28.9%; 95% CI, 23.1–35.5). Higher recorded epilepsy prevalence was associated with female sex (adjusted prevalence ratio [aPR], 1.62; 95% CI, 1.04–2.54), ASD diagnosis at 6–17 versus 2–5 years (1.88; 1.10–3.21), and a global developmental delay label versus language delay/impairment (2.23; 1.22–4.06). Estimates for regression and intellectual disability were imprecise. Extreme assumptions about all 17 missing outcomes yielded prevalence bounds of 26.7%–34.4% across all 221 entries. Conclusions Recorded epilepsy affected approximately three in ten children with documented status. Referral selection, missing outcomes, and retrospective documentation limit causal interpretation and population generalizability.
No takes yet. Share an insight, caveat, or question.
Maimounah¹ et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: